07:00 , Sep 2, 2013 |  BC Week In Review  |  Company News

Simcere deal

Simcere said it is going private in a deal in which Chairman Jinsheng Ren and Assure Ahead Investments Ltd. will acquire all of the Simcere shares they do not already own for $4.83 per share...
07:00 , Sep 2, 2013 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Regulatory milestones Allenex AB (SSE:ALNX) gained SEK1.03 (48%) to SEK3.19 on Thursday after saying Mexico approved XM-ONE to detect human leukocyte antigen (HLA) and non-HLA antibodies between donor and recipient in organ transplantations. XM-ONE is...
00:33 , Aug 29, 2013 |  BC Extra  |  Company News

Simcere to go private

Simcere Pharmaceutical Group (NYSE:SCR) said it is going private in a deal in which Chairman Jinsheng Ren and Assure Ahead Investments Ltd. will acquire all of the Simcere shares they do not already own for...
07:00 , Aug 19, 2013 |  BioCentury  |  Finance

Jumping on the gravy train

Clarus Ventures and Aisling Capital jumped on an opportunity to return money to investors through potential royalties for cancer compound ibrutinib, but the firms don't plan to make a habit of investing in royalty streams....
07:00 , Apr 8, 2013 |  BC Week In Review  |  Company News

Simcere deal

Simcere said its special committee retained UBS as its financial advisor in considering a non-binding proposal to go private from Chairman Jinsheng Ren and Assure Ahead Investments Ltd. The parties are proposing to acquire all...
07:00 , Mar 18, 2013 |  BC Week In Review  |  Company News

Simcere deal

Simcere said its board received a non-binding proposal to go private from Chairman Jinsheng Ren and Assure Ahead Investments Ltd. The parties are proposing to acquire all of the Simcere shares they do not already...
07:00 , Mar 18, 2013 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Regulatory milestones Biogen Idec Inc. (NASDAQ:BIIB) gained $4.40 to $176.78 last week after submitting a BLA to FDA for rFVIIIFc to treat hemophilia A. The product is partnered with Swedish Orphan Biovitrum AB (SSE:SOBI), which...
00:07 , Mar 12, 2013 |  BC Extra  |  Company News

Simcere receives proposal to go private

Simcere Pharmaceutical Group (NYSE:SCR) said its board received a non-binding proposal to go private from Chairman Jinsheng Ren and Assure Ahead Investments. The parties are proposing to acquire all of the Simcere shares they do...